Buerger disease: Nursing

Buerger disease: Nursing

Watch later

Watch later

Infection prevention and control - Precautions and personal protective equipment (PPE): Nursing skills
Urinary tract infections (UTIs): Nursing process (ADPIE)
Modes of infectious disease transmission
Epstein-Barr virus (Infectious mononucleosis)
Pneumonia
Wound healing
Palliative and hospice care: Nursing
Postoperative care: Nursing
Biology of cancer: Nursing
Biliary atresia: Nursing
Cholecystitis: Nursing
Cholelithiasis: Nursing
Colorectal cancer: Nursing
Diarrhea: Nursing
Diverticular disease: Nursing
Esophageal cancer: Nursing
Gastric cancer: Nursing
Hepatitis: Nursing
Inflammatory bowel disease - Crohn disease and ulcerative colitis: Nursing
Intestinal obstruction: Nursing
Irritable bowel syndrome (IBS): Nursing
Jaundice: Nursing
Laryngeal cancer: Nursing
Liver cancer: Nursing
Pancreatic cancer: Nursing
Esophageal atresia and tracheoesophageal fistula: Nursing
Geriatric considerations - Gastrointestinal: Nursing
Hirschsprung disease: Nursing
Hyperemesis gravidarum: Nursing
Necrotizing enterocolitis: Nursing
Omphalocele and gastroschisis: Nursing
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Antiemetics: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Laxatives: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Pancreatic enzyme replacements: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Bladder tumors: Nursing
Chronic kidney disease (CKD): Nursing
Dialysis care: Nursing
Epididymitis: Nursing
Glomerulonephritis: Nursing
Nephrotic syndrome: Nursing
Polycystic kidney disease (PKD): Nursing
Prostate cancer: Nursing
Pyelonephritis: Nursing
Renal and urinary calculi: Nursing
Renal cancer: Nursing
Testicular cancer: Nursing
Urinary retention: Nursing
Bladder exstrophy: Nursing
Circumcision: Nursing
Cryptorchidism: Nursing
Enuresis: Nursing
Geriatric considerations - Urinary: Nursing
Hypospadias and epispadias: Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Anemia - Aplastic: Nursing
Anemia - Iron-deficiency: Nursing
Anemia - Macrocytic: Nursing
Arterial blood gas (ABG) - Overview: Nursing
Arterial blood gas (ABG) - Metabolic acidosis: Nursing
Arterial blood gas (ABG) - Metabolic alkalosis: Nursing
Arterial blood gas (ABG) - Respiratory acidosis: Nursing
Arterial blood gas (ABG) - Respiratory alkalosis: Nursing
Blood cultures: Nursing
Cardiac biomarkers - Creatine kinase (CK): Nursing
Cardiac biomarkers - Troponin: Nursing
Coagulation studies - Partial thromboplastin time (PTT): Nursing
Complete blood count (CBC) - Hemoglobin and hematocrit: Nursing
Complete blood count (CBC) - Platelets: Nursing
Complete blood count (CBC) - Red blood cells (RBC): Nursing
Complete blood count (CBC) - White blood cells (WBC) and differential: Nursing
Complete metabolic panel (CMP) - Blood urea nitrogen (BUN) and creatinine (Cr): Nursing
Complete metabolic panel (CMP) - Chloride: Nursing
Complete metabolic panel (CMP) - Estimated glomerular filtration rate (eGFR): Nursing
Complete metabolic panel (CMP) - Glucose: Nursing
Complete metabolic panel (CMP) - Liver function tests (LFT): Nursing
Complete metabolic panel (CMP) - Potassium: Nursing
Complete metabolic panel (CMP) - Sodium: Nursing
Complete metabolic panel (CMP) - Total protein: Nursing
Disseminated intravascular coagulation (DIC): Nursing
Multiple myeloma: Nursing
Neutropenia: Nursing
Polycythemia: Nursing
Thalassemia: Nursing
Thrombocytopenia: Nursing
Leukemia: Nursing process (ADPIE)
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Blood products: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Autoimmunity: Nursing
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS): Nursing
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type II: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Type IV: Nursing
Immune response - Adaptive: Nursing
Immune response - Innate: Nursing
Immunodeficiency disorders - Primary: Nursing
Immunodeficiency disorders - Secondary: Nursing
Inflammatory process: Nursing
Scleroderma: Nursing
Shock - Anaphylactic: Nursing
Sjögren syndrome: Nursing
Systemic lupus erythematosus (SLE): Nursing
Toxic shock syndrome (TSS): Nursing
Erythema infectiosum (Fifth disease): Nursing
Fever: Nursing
Infectious mononucleosis: Nursing
Mumps (Parotitis): Nursing
Neonatal sepsis: Nursing
Pertussis: Nursing
Poliomyelitis: Nursing
Postpartum infections: Nursing
Roseola (Exanthem subitum): Nursing
Rubella (German measles): Nursing
Rubeola (Measles): Nursing
Smallpox: Nursing
Zika virus: Nursing
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Antirejection immunosuppressants: Nursing pharmacology
Biologic agents: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Vaccines: Nursing pharmacology
Acne: Nursing
Animal and snake bites: Nursing
Burn injury: Nursing
Cutaneous fungal infections: Nursing
Erysipelas and cellulitis: Nursing
Folliculitis, carbuncles, and furuncles: Nursing
Herpes simplex virus (HSV): Nursing
Herpes zoster: Nursing
Impetigo: Nursing
Insect stings and bites: Nursing
Pediculosis and scabies: Nursing
Psoriasis: Nursing
Rocky Mountain spotted fever (RMSF): Nursing
Skin cancer - Basal cell carcinoma, squamous cell carcinoma, and melanoma: Nursing
Urticaria: Nursing
Geriatric considerations - Integumentary: Nursing
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Osteoarthritis: Nursing
Osteomyelitis: Nursing
Osteoporosis: Nursing
Hip fractures: Nursing
Developmental dysplasia of the hip: Nursing
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Buerger disease: Nursing
Raynaud phenomenon: Nursing
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Atelectasis: Nursing
Geriatric considerations - Respiratory: Nursing
Venous thromboembolism (VTE): Nursing process (ADPIE)
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Bronchiolitis and respiratory syncytial virus (RSV): Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Papulosquamous and inflammatory skin disorders: Pathology review

Notes

BUERGER DISEASE

KEY POINTS
NOTES
DEFINITION
  • Thrombophlebitis obliterans
  • Peripheral vascular condition characterized by inflammation of small- and medium-sized arteries and veins

PHYSIOLOGY
  • Arteries
    • Tunica externa (adventitia)
    • Tunica media
    • Endothelium
      • Lamina propria
  • Veins
  • Capillaries
    • Oxygen and nutrients pass to cells which return carbon dioxide and wastes
  • Blood flow
    • Large arteries > medium arteries > arterioles > capillary bed > venues > medium veins > large veins
  • Endothelial cells
    • Prevent blood cells from reaching lamina propria

CAUSES AND RISK FACTORS
  • Causes
    • Unknown 
  • Risk factors
    • Long-term tobacco use
    • Marijuana use
    • Assigned male at birth
    • Age 25-35 years

PATHOPHYSIOLOGY
  • Acute
    • Inflammatory thrombus forms within walls of small- and medium-sized vessels
    • Thrombus matures and enlarges
  • Chronic
    • Proliferation of fibroblasts and collagen deposition
    • Vessels narrow
    • Blood flow to tissues decreased 
    • Tissue ischemia and death

SIGNS AND SYMPTOMS
  • Intermittent claudication
  • Ulcers
  • Paresthesia
  • Skin color or temperature changes
  • Raynaud phenomenon
  • Delayed capillary refill time
  • Necrosis
  • Gangrene

DIAGNOSIS
  • History
  • Physical assessment
  • Allen test
  • Ankle-brachial index (ABI)

TREATMENT
  • Tobacco and marijuana cessation
  • Avoidance of triggers
  • Analgesics
  • Calcium channel blockers
  • Phosphodiesterase-5 inhibitors
  • Topical nitrates
  • Antibiotics
  • Surgery

MANAGEMENT OF CARE
  • Goals of care 
    • Promote blood flow
    • Prevent infection
    • Manage pain
  • Assess extremities 
    • Notify HCP
      • Signs or symptoms of tissue necrosis
  • Administer medications as prescribed
  • Assess for signs of infection
  • Assess pain

PATIENT AND FAMILY TEACHING
  • Explain condition, plan of care, and how to safely self-administer medications
  • Develop tobacco cessation plan
  • Provide follow-up appointments
  • Refer to local support group
  • Remind to avoid triggers
  • Encourage physical activity and maintaining skin integrity
  • Avoid sores on feet
  • Clean wounds promptly
  • Notify HCP
    • Slow healing wound
    • Signs of infection
    • Signs or symptoms of gangrene

Transcript

Watch video only

Buerger disease, also called thromboangiitis obliterans, is a peripheral vascular condition characterized by inflammation of small and medium-sized arteries and veins of the extremities. This inflammation is recurrent, segmental, and non-atherosclerotic, meaning that it’s not caused by atherosclerosis.

All right, let’s go over some physiology. There are three major types of blood vessels: arteries, veins, and capillaries. Normally, blood flows from large arteries into medium and then small arteries called arterioles, which in turn, carry the blood to capillary beds. All arterial vessels have three layers: from outside in, there’s tunica externa or the adventitia layer, which has loose connective tissue; then the tunica media or the media layer, which contains some elastic tissue and smooth muscle that allow the arteriole to dilate or constrict in response to local conditions; and finally, the endothelium, which consists of a single layer of endothelial cells on top of a layer of connective tissue, called lamina propria.

The endothelial cells maintain blood flow by preventing blood cells from reaching the underlying lamina propria. If their continuity is disrupted, blood cells may come up against coagulation factors in the lamina propria. This initiates a coagulation cascade that leads to the formation of a blood clot, which in turn blocks the blood flow.

Now, the arterioles deliver oxygen-rich blood into a network of capillaries, called the capillary bed. Here, oxygen and nutrients pass to tissue cells, which will then return carbon dioxide and wastes back into the capillary bed. These capillaries will then merge to form the smallest veins, called the venules. The structure of these venules is similar to that of arterioles but with thinner walls that contain less smooth muscles. Eventually, these venules drain blood into medium veins, which then drain into large veins that deliver the blood straight back to the heart.

All right, now the exact cause of Buerger disease is still unknown, however the single most important risk factor is long-term tobacco use. Other risk factors include marijuana use, clients assigned male at birth, and age between 25 and 35, without other cardiovascular disease risk factors like hypertension, hyperlipidemia, and diabetes.

Now, the course of Buerger disease consists of two phases: acute and chronic. In the acute phase, an inflammatory thrombus forms within the walls of small and medium-sized blood vessels. At first, this thrombus is filled with immune cells, but later on, organization may occur, which describes the migration of more cells into the thrombus, like smooth muscle cells and fibroblasts.

As this thrombus matures and gets larger, the disease progresses into the chronic phase, which is characterized by vascular fibrosis, meaning proliferation of fibroblasts and collagen deposition. The enlarging thrombus and the resulting vascular fibrosis narrow the blood vessels, decreasing the blood flow to the tissues, and eventually causing tissue ischemia and death.

Clients with Buerger disease typically present with intermittent claudication, which is intermittent pain that most often affects the calf, but can also involve the foot, thigh, or even the arms, and is induced by exercise and relieved by rest. In cases of advanced disease, this pain may even come at rest, along with ulcers that result from the ischemia, called ischemic ulcerations.

Other signs and symptoms that may arise in the affected limb include paresthesia, as well as skin color and temperature changes. Some clients may also present with Raynaud phenomenon, meaning that when exposed to a trigger, such as emotional stress or exposure to cold temperatures, their fingers and toes turn white, then blue, and then red.

Additionally, clients with Buerger disease may have delayed capillary refill time, which indicates hypoperfusion of the involved tissue. In the most severe cases, the client could develop necrosis and gangrene.

Now, the diagnosis of Buerger disease is usually based mostly on history and physical assessment. Diagnostic tests may include an Allen test to assess the degree of arterial circulation to the client’s hands. This can be followed by the ankle–brachial index or ABI test to rule out peripheral artery disease. Finally, additional tests should focus on ruling out other unrelated conditions that may also present with intermittent claudication, such as thrombophilia, diabetic neuropathy, aneurysms of the popliteal artery, and autoimmune diseases, like scleroderma.

When treating a client with Buerger disease, the goals are to prevent ischemic tissue damage and improve quality of life. Initial treatment is typically focused on the complete cessation of tobacco, including nicotine replacement products, in addition to the complete cessation of marijuana use in any form. Avoiding triggers like cold exposure may also help prevent Raynaud phenomenon. If this is not enough, the client can be given analgesics for the pain, as well as medications that help induce vasodilation and improve blood flow to the extremities, such as calcium channel blockers, phosphodiesterase-5 inhibitors, or topical nitrates. Clients with infected ulcers may also require antibiotics.

Now, in severe refractory cases, surgical treatment options might be considered, such as lumbar sympathectomy. This is when surgery is performed to cut the sympathetic nerve fibers supplying the affected areas. This reduces leg pain associated with ischemia, and aids in the healing of ischemic ulcers. The next option is implanting a spinal cord stimulator, which is a small device that sends low electrical pulses to the spinal cord to reduce pain. Finally, necrotic areas may require surgical debridement or even amputation.

All right, now let’s look at the nursing care you will be providing a client with Buerger disease. Priority goals of care center on promoting blood flow to affected areas, preventing infection, and managing pain. Begin by assessing your client’s extremities, including blood pressure, distal pulses, capillary refill, skin color and sensation, and the presence of ulcers.